Althea Group
We are early stage investors. We offer growth capital and strategic advisory.
Investments Include
Private Market Transaction
Private Market Transaction
Private Market Transaction
Developing next generation genetic medicines with safe, effective, and redosable nucleic acid delivery technologies
Seed
Private Market Transaction
Private Market Transaction
Breakthrough Fusogenix gene delivery technology used to combat and treat COVID-19
Seed
Private Market Transaction
Next generation cancer therapy targeting P53 delivered through a patented proteo-lipid vehicle
Seed
DNA-targeted intervention
to clear senescent cells
Seed
Intellectual property (IP) management software - Automated trademark docketing
Seed to Exit
RxTransparent acquired by
Inmar Intelligence, a
portfolio company of OMERS
Seed
Femtech. IoT enabled tracker measures changes in cervical fluid, aiding women's reproductive health
Seed
Personalized digestive health. Dieta solves IBS using data and AI
Seed
Pre-Seed
Revolutionary new test for Endometriosis
Pre-Seed
Seed to Exit
Pre-Seed
Remote biofeedback for telehealth providers and patients
Seed
Seed to Exit
Seed to Exit
Sea Monsters snacks (CPG)
Seed to Exit
Seed to Exit
Seed to Exit
Financial advisor
transition management